10:49 EDT FDA says Eli Lilly’s Zepbound at limited availability through April
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Can Eli Lilly Stock Continue Its Bull Run? Here’s What Citi Expects
- Eli Lilly price target raised to $895 from $675 at Citi
- ResMed price target raised to $224 from $215 at Needham
- Lilly’s Zepbound in short supply at Amazon Pharmacy, Rite Aid, Bloomberg says
- Early notable gainers among liquid option names on March 28th
Questions or Comments about the article? Write to editor@tipranks.com